Near $200 – Are Cochlear (ASX:COH) Shares Finally Cheap?
David Lennan
October 22, 2019
Cochlear Limited (ASX:COH) shares were down 4% today following their
CSL Limited (ASX: CSL) is Australia’s largest (and some might say best) healthcare company, specialising in biopharmaceuticals. Founded in the late 1900s as the Commonwealth Serum Laboratories, CSL was sold by the Australian Government to Australian investors via the share market in 1994 at $2.30 per share, at which time it doubled its size through an international acquisition. CSL is a global leader in blood plasma vaccines (think: the flu) and antivenoms, providing relief for potentially life-threatening medical conditions.
Cochlear Limited (ASX:COH) shares were down 4% today following their
Plenty of investors are drawn to the idea of blue
The RBA governor has suggested that the central bank may
The CSL Limited (ASX:CSL) share price hit a new all-time
Shares in CSL Limited (ASX: CSL) hit a new all
Healthcare companies around the world right now have tailwinds and
Most Australian investors have a large exposure to financial companies
If the Australian dollar continues to fall against the US
Would it be a good idea to buy $1,000 of
Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best insights.
